Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02915978 · ClinicalTrials.gov registry record · Phase 2
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
A Phase 2 study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT02915978 is a Phase 2 study that has completed, run by INSYS Therapeutics. The registered enrollment target is 45 participants.
The verdict
NCT02915978, a Phase 2 study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.
Interventions
- DRUG Placebo
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-02-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02915978
The ClinicalTrials.gov registry entry for NCT02915978 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is INSYS Therapeutics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02915978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02915978 about?
NCT02915978 is a clinical study titled "Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain". The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.
What is the current status of trial NCT02915978?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2016-12. Estimated completion is 2017-02-10.
What interventions are being tested in trial NCT02915978?
The interventions under investigation include: Placebo (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT02915978?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.